View the original post at businesswire.com EDMONTON, Alberta–(BUSINESS WIRE)–48Hour Discovery Inc. (48HD) and Quantum Intelligence Corp. (QIC) announced today the establishment of a joint...

(From the PharmNews website of the Korean Business Journal. 출처 : 팜뉴스http://www.pharmnews.com) View the original post at pharmnews.com Novacell Technology Co., Ltd. (Novacell), a Korean biotechnology company that...

EDMONTON, ALBERTA (September 25, 2020) – 48Hour Discovery Inc. announced today that it has filed a US provisional patent that describes a novel method for...

Edmonton-based biotech 48Hour Discovery is invited to travel to Pangyo Technoo Valley, the Korean version of the Silicon Valley, to expand their technology into...

A University of Alberta spinoff company is adding their cutting-edge technology to the search for antiviral compounds to treat individuals infected with COVID-19. 48Hour...

48Hour Discovery Inc. announced today that it has initiated drug discovery projects for therapeutic targets related to COVID-19. 48Hour Discovery Inc. is using its proprietary technology...

New technology platform would deliver orally available small molecule therapeutics for a wide range of targets EDMONTON, ALBERTA (April 18, 2019) – 48Hour Discovery (48HD)...

Collaboration receives $300,000 CAD grant to further develop and commercialize TumorGenesis oncology discovery technologies MINNEAPOLIS, April 16, 2019 (GLOBE NEWSWIRE) – Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision”...

EDMONTON, ALBERTA (April 15, 2019) – 48Hour Discovery INC., a biotechnology company focused on the discovery of peptide-derived small molecule therapeutics, is pleased to welcome Dr....

EDMONTON, ALBERTA (March 11, 2019) – 48Hour Discovery Inc. announced the appointment of David Alton as the Director of Business Development, effective March 11, 2019....